| Dr Bonnie W Cheung, MD | |
|
10 Congress St, Suite 511, Pasadena, CA 91105-3045 | |
| (626) 796-0360 | |
| Not Available |
| Full Name | Dr Bonnie W Cheung |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology - Maternal & Fetal Medicine |
| Location | 10 Congress St, Pasadena, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194740480 | NPI | - | NPPES |
| 000000509153 | Other | OH | ANTHEM |
| 7835617 | Other | OH | AETNA |
| 2493494 | Medicaid | OH | |
| 221434 | Other | OH | UNISON |
| Entity Name | Magella Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376640086 PECOS PAC ID: 7214827591 Enrollment ID: O20040318001666 |
News Archive
As health departments across the United States seek a better way to determine which children should be tested for lead poisoning, a method created by Michigan State University scientists has proven to be more accurate and cost-effective than current strategies.
A group of researchers from EPFL's Global Health Institute (GHI) and Inserm (Institut National de la Sant- et de la Recherche M-dicale, the French government agency for biomedical research) has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria. The discovery could quickly open up a whole new strategy for combating this deadly disease.
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
Veredus Laboratories, a leading provider of molecular detection tests, and its technology partner, STMicroelectronics, today announced the successful development and deployment of VereFoodborne, a Lab-on-Chip application that is able to detect 10 to 12 food-borne pathogens in one test, including the Shiga toxin-producing Escherichia coli responsible for the recent severe food poisoning outbreak in Europe.
› Verified 4 days ago
| Entity Name | Valley Childrens Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437555265 PECOS PAC ID: 9032439336 Enrollment ID: O20150528001593 |
News Archive
As health departments across the United States seek a better way to determine which children should be tested for lead poisoning, a method created by Michigan State University scientists has proven to be more accurate and cost-effective than current strategies.
A group of researchers from EPFL's Global Health Institute (GHI) and Inserm (Institut National de la Sant- et de la Recherche M-dicale, the French government agency for biomedical research) has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria. The discovery could quickly open up a whole new strategy for combating this deadly disease.
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
Veredus Laboratories, a leading provider of molecular detection tests, and its technology partner, STMicroelectronics, today announced the successful development and deployment of VereFoodborne, a Lab-on-Chip application that is able to detect 10 to 12 food-borne pathogens in one test, including the Shiga toxin-producing Escherichia coli responsible for the recent severe food poisoning outbreak in Europe.
› Verified 4 days ago
| Entity Name | Access Telecare Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013303080 PECOS PAC ID: 7810204831 Enrollment ID: O20190531002079 |
News Archive
As health departments across the United States seek a better way to determine which children should be tested for lead poisoning, a method created by Michigan State University scientists has proven to be more accurate and cost-effective than current strategies.
A group of researchers from EPFL's Global Health Institute (GHI) and Inserm (Institut National de la Sant- et de la Recherche M-dicale, the French government agency for biomedical research) has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria. The discovery could quickly open up a whole new strategy for combating this deadly disease.
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
Veredus Laboratories, a leading provider of molecular detection tests, and its technology partner, STMicroelectronics, today announced the successful development and deployment of VereFoodborne, a Lab-on-Chip application that is able to detect 10 to 12 food-borne pathogens in one test, including the Shiga toxin-producing Escherichia coli responsible for the recent severe food poisoning outbreak in Europe.
› Verified 4 days ago
| Entity Name | Access Telecare California Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861959959 PECOS PAC ID: 8325373525 Enrollment ID: O20190710002532 |
News Archive
As health departments across the United States seek a better way to determine which children should be tested for lead poisoning, a method created by Michigan State University scientists has proven to be more accurate and cost-effective than current strategies.
A group of researchers from EPFL's Global Health Institute (GHI) and Inserm (Institut National de la Sant- et de la Recherche M-dicale, the French government agency for biomedical research) has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria. The discovery could quickly open up a whole new strategy for combating this deadly disease.
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
Veredus Laboratories, a leading provider of molecular detection tests, and its technology partner, STMicroelectronics, today announced the successful development and deployment of VereFoodborne, a Lab-on-Chip application that is able to detect 10 to 12 food-borne pathogens in one test, including the Shiga toxin-producing Escherichia coli responsible for the recent severe food poisoning outbreak in Europe.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bonnie W Cheung, MD 436 Adrian Ct, Claremont, CA 91711-1601 Ph: (216) 337-3670 | Dr Bonnie W Cheung, MD 10 Congress St, Suite 511, Pasadena, CA 91105-3045 Ph: (626) 796-0360 |
News Archive
As health departments across the United States seek a better way to determine which children should be tested for lead poisoning, a method created by Michigan State University scientists has proven to be more accurate and cost-effective than current strategies.
A group of researchers from EPFL's Global Health Institute (GHI) and Inserm (Institut National de la Sant- et de la Recherche M-dicale, the French government agency for biomedical research) has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria. The discovery could quickly open up a whole new strategy for combating this deadly disease.
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
Veredus Laboratories, a leading provider of molecular detection tests, and its technology partner, STMicroelectronics, today announced the successful development and deployment of VereFoodborne, a Lab-on-Chip application that is able to detect 10 to 12 food-borne pathogens in one test, including the Shiga toxin-producing Escherichia coli responsible for the recent severe food poisoning outbreak in Europe.
› Verified 4 days ago
Dr. Jonathan Nei-kim Tam, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 105 N Hill Ave Ste 203, Pasadena, CA 91106 Phone: 626-449-2800 Fax: 626-795-5145 | |
John Gordon Wilcox, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 333 S Arroyo Pkwy, Pasadena, CA 91105 Phone: 626-440-9161 Fax: 626-585-1603 | |
Paul Sc Lin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 960 E Green St Ste L-60, Pasadena, CA 91106 Phone: 626-793-3339 Fax: 626-793-3118 | |
Jeffrey Robert Nelson, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 333 S Arroyo Pkwy, Pasadena, CA 91105 Phone: 626-440-9161 Fax: 626-585-1603 | |
Dr. James Armen Macer, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10 Congress St, Suite 400, Pasadena, CA 91105 Phone: 626-449-6223 Fax: 626-449-0035 | |
Aaron J Epstein, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 50 Alessandro Pl Ste 210, Pasadena, CA 91105 Phone: 626-514-0060 Fax: 626-514-0062 | |
Dr. George Toshinori Matsuda, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10 Congress St, Suite 400, Pasadena, CA 91105 Phone: 626-449-6223 Fax: 626-449-0035 |